NEW YORK (GenomeWeb) – Two new blood screening assays developed by Grifols have been cleared by the US Food and Drug Administration, the firm announced today.
The Procleix Ultrio Elite is a combined screening test for the HIV-1, hepatitis B, and hepatitis C viruses, and also enables detection of HIV-2. It can be used to test pools of plasma composed of up to 96 plasma donor samples. The Procleix WNV test screens serum and plasma donations for West Nile virus. The tests run on Grifols' Procleix Panther system.